Electrophysiologic procedures and activation of the hemostatic system

被引:34
作者
Michelucci, A
Antonucci, E
Conti, AA
Liotta, AA
Fedi, S
Padeletti, L
Porciani, MC
Prisco, D
Abbate, R
Gensini, GF
机构
[1] Univ Florence, Ist Clin Med Gen & Cardiol, I-50134 Florence, Italy
[2] Azienda Osped Careggi, Florence, Italy
关键词
D O I
10.1016/S0002-8703(99)70257-7
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background Thromboembolism occurs in 0.4% to 2% of the subjects undergoing rodiofrequency ablation (RFA), but its mechanisms remain unclear. Our aim was to evaluate several parameters of the hemostatic system in relation to the electrophysiologic procedure. Methods Thirty consecutive patients were enrolled in the study. Fifteen underwent electrophysiologic study and 15 underwent radiofrequency ablation. Before the ablation procedure, all subjects were given on intravenous heparin bolus (2500 IU). Blood samples were drown immediately before, at the end of, and 24 hours offer the procedures. Spontaneous platelet aggregation in whale blood and in platelet rich plasma, markers of clotting activation (prothrombin fragment 1+2 and the thrombinantithrombin complex) and the fibrinolytic system (plasminogen activator inhibitor and D-dimer) levels were evaluated, Results At the end of the procedure, spontaneous platelet aggregation in whole blood, prothrombin fragment 1+2, thrombin-antithrombin complex, and D-dimer levels increased significantly in all patients. The hemostatic changes were more marked after RFA than after electrophysiology. Spontaneous aggregation in whole blood, prothrombin fragment 1+2, and thrombin-antithrombin complex levels at 24 hours after the procedure were similar to those observed before the procedure in both groups; D-dimer levels were still elevated with respect to preprocedure levels, with a trend toward higher levels in patients undergoing RFA rather than electrophysiology. A significantly more marked activation of coagulation (prothrombin fragment 1+2, P < .005) was found in patients in whom the mean duration of energy application was higher than 23.5 seconds, Conclusions Our data suggest that antithrombotic prevention with a prolonged administration of heparin and/or the association of antiplatelet agents should be considered in patients undergoing RFA.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 18 条
[1]
Low-dose heparin pretreatment is not able to prevent clotting activation during coronary angiography [J].
Capanni, M ;
Antonucci, E ;
Chiarugi, L ;
Giglioli, C ;
Margheri, M ;
Simonetti, I ;
Prisco, D ;
Abbate, R ;
Gensini, GF .
THROMBOSIS RESEARCH, 1998, 91 (03) :151-153
[2]
Hemostatic abnormalities in inflammatory bowel disease [J].
Chiarantini, E ;
Valanzano, R ;
Liotta, AA ;
Cellai, AP ;
Fedi, S ;
Ilari, I ;
Prisco, D ;
Tonelli, F ;
Abbate, R .
THROMBOSIS RESEARCH, 1996, 82 (02) :137-146
[3]
EVIDENCE FOR A RAPID INHIBITOR TO TISSUE PLASMINOGEN-ACTIVATOR IN PLASMA [J].
CHMIELEWSKA, J ;
RANBY, M ;
WIMAN, B .
THROMBOSIS RESEARCH, 1983, 31 (03) :427-436
[4]
Embolic complications associated with radiofrequency catheter ablation [J].
Epstein, MR ;
Knapp, LD ;
Martindill, M ;
Lulu, JA ;
Triedman, JK ;
Calkins, H ;
Huang, SKS ;
Walsh, EP ;
Saul, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (08) :655-+
[5]
RELEASE OF AUTONOMIC MEDIATORS IN CARDIAC TISSUE BY SUPRATHRESHOLD STIMULATION [J].
FURCHGOTT, RF ;
GUBAREFF, TD ;
GROSSMAN, A .
SCIENCE, 1959, 129 (3345) :328-328
[6]
TRANSESOPHAGEAL ECHOCARDIOGRAPHIC EVALUATION FOR MURAL THROMBUS FOLLOWING RADIOFREQUENCY CATHETER ABLATION OF ACCESSORY PATHWAYS [J].
GOLI, VD ;
PRASAD, R ;
HAMILTON, K ;
MOULTON, KP ;
TYLER, M ;
LOGAN, P ;
LAZZARA, R ;
JACKMAN, WM .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (11) :1992-1997
[7]
CARDIOVASCULAR COMPLICATIONS AFTER RADIOFREQUENCY CATHETER ABLATION OF SUPRAVENTRICULAR TACHYARRHYTHMIAS [J].
GREENE, TO ;
HUANG, SKS ;
WAGSHAL, AB ;
MITTLEMAN, RS ;
PIRES, LA ;
MAZZOLA, F ;
ANDRESS, JD .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (06) :615-617
[8]
HAINES DE, 1994, CATHETER ABLATION AR, P105
[9]
THE MULTICENTER-EUROPEAN-RADIOFREQUENCY-SURVEY (MERFS) - COMPLICATIONS OF RADIOFREQUENCY CATHETER ABLATION OF ARRHYTHMIAS [J].
HINDRICKS, G ;
ALIOT, E ;
ALMENDRAL, JM ;
AMLIE, J ;
ARLOTTI, M ;
BARNAY, C ;
BASHIR, Y ;
BERGFELDT, L ;
BLANC, J ;
HIMBERT, J ;
THOMSEN, PEB ;
BLOMSTROMLUNDQVIST, C ;
BREMBILLAPERROT, B ;
BRUGADA, P ;
BRUGADA, J ;
COWAN, JC ;
CAUCHEMEZ, B ;
CLEMENTY, J ;
COBBE, S ;
CRITELLI, G ;
CRIJNS, H ;
DAUBERT, JC ;
DESOUSA, J ;
DJIANE, P ;
DONZEAU, JP ;
DUCKECK, W ;
EDWARDSSON, N ;
FARRE, J ;
COSNAY, P ;
FONTAINE, G ;
FROMER, M ;
GOICOLEA, A ;
GONSKA, BD ;
GROLLEAURAOUX, R ;
HAISSAGUERRE, M ;
HAVERKAMP, W ;
HERMIDA, JS ;
HIEF, C ;
HOPP, HW ;
HOFFMAN, E ;
HUIKURI, H ;
JORDAENS, L ;
KALUSCHE, D ;
KUHLKAMP, V ;
LAUCEVICIUS, A ;
LAVERGNE, T ;
MANZ, M ;
MOLLER, M ;
MONT, L ;
NATHAN, AW .
EUROPEAN HEART JOURNAL, 1993, 14 (12) :1644-1653
[10]
HINDS EA, 1994, ADV AT MOL OPT PHY S, V2, P1